Curetis
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Max-eyth-str. 42, Holzgerlingen, Baden-W...Phone Number
+49 70314919555Website
www.curetis.comRevenue
$17.4 MillionStock Symbol
CUREIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Curetis
Curetis, founded in 2007 and based in Germany, goal is a provider of innovative solutions for molecular microbiology diagnostics designed to address the global challenge of detecting severe infectious diseases and identifying antibiotic resistances in hospitalized patients.Explore more
Curetis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curetis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Curetis, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Curetis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Curetis had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Curetis
Check out if Curetis is spiking on competitors!
Earning: See what the market has to say on Curetis recently announced quarterly report
Funding: Get notified immidiatlly once Curetis has new funding data
Product Launch: Get notified when Curetis launches new products
Recommended Actions
Find VP level buyers at Curetis
Find 3 more new buyers
Company Profile Activity
Activity Insights
Curetis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Curetis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Curetis.
Curetis financials insights
Gather financial insights about Curetis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$42.9M
2016
Debt
$26.4M
2020
Debt
$5.7M
Curetis Tech Stack
A closer look at the technologies used by Curetis
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Mergers & Acquisitions (M&A)
Curetis News & Media
OpGen’s Subsidiary Curetis and European Investment Bank Plan to Restructure Debt Repayment
ROCKVILLE, Md., April 25, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that its subsidiary, Curetis GmbH (“Curetis”), and the European Investment Bank (EIB) expect to restructure the repayment of the first tranche which matured on April 22, 2022.OpGen Appoints Albert Weber as Chief Financial Officer
ROCKVILLE, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced the appointment of Albert Weber as OpGen’s new Chief Financial Officer and Managing Director of OpGen’s subsidiary Curetis GmbH effective January 1, 2022.OpGen Achieves Key Development Milestone in Unyvero A30 RQ Platform Program
- OpGen subsidiary Curetis and its instrument development partner have completed assembly of 10 final pre-series release A30 RQ analyzersCuretis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report
Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 30, 2020, 08:00 am CET - Curetis N.V. in liquidatie (the "Company") today announced that the publication of its audited 2019 full year financial results and 2019 Annual Report originally scheduled for April 30, 2020 will be delayed to a later date expected in May 2020. The delay is caused by the impact of the COVID-19 pandemic on the Company’s finance department’s operations, its external advisors, including a
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Curetis
Sign Up For FreeTo access detailed company insights
Curetis, founded in 2007 and based in Germany, goal is a provider of innovative solutions for molecular microbiology diagnostics designed to address the global challenge of detecting severe infectious diseases and identifying antibiotic resistances in hospitalized patients.... Read More
